The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Interleukin 1 (IL1) - Drugs in Development, 2021
US$ 3,500.00
Interleukin 1 (IL1) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Interleukin 1 - Drugs in Development, 2021'; Interleukin 1 (IL1) pipeline Target constitutes close...
March 2021
162 pages
Mumps (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Mumps (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mumps - Drugs in Development, 2021, provides an over...
March 2021
34 pages
Myasthenia Gravis (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Myasthenia Gravis (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myasthenia Gravis - Drugs in Development, 2021,...
March 2021
283 pages
Plague (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Plague (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plague - Drugs in Development, 2021, provides an ov...
March 2021
51 pages
Sarcopenia (Musculoskeletal) - Drugs in Development, 2021
US$ 2,000.00
Sarcopenia (Musculoskeletal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia - Drugs in Development, 2021, provides...
March 2021
102 pages
Smallpox (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Smallpox (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Smallpox - Drugs in Development, 2021, provides a...
March 2021
88 pages
